| scholarly article | Q13442814 |
| P2093 | author name string | Jiang Xu | |
| Nour-Eddine Rhaleb | |||
| Oscar A Carretero | |||
| Xiao-Ping Yang | |||
| Edward L Peterson | |||
| Branislava Janic | |||
| Hongmei Peng | |||
| Nadia Rhaleb | |||
| Zeyd Sarwar | |||
| P2860 | cites work | Alternative activation of macrophages: mechanism and functions | Q29614350 |
| Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. | Q30443462 | ||
| Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart | Q30471805 | ||
| IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells | Q31763724 | ||
| Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension | Q33764751 | ||
| Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts | Q34020430 | ||
| Cardiac mast cells: the centrepiece in adverse myocardial remodelling | Q34410300 | ||
| Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor | Q34412392 | ||
| Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation | Q35083309 | ||
| Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart | Q35103548 | ||
| CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis | Q35159918 | ||
| Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction. | Q35942679 | ||
| Cytokine-induced modulation of cardiac function | Q35980361 | ||
| The cardiac fibroblast: therapeutic target in myocardial remodeling and failure | Q36094597 | ||
| Cytokines and cardiovascular disease | Q36188431 | ||
| The relationship between myocardial extracellular matrix remodeling and ventricular function | Q36578692 | ||
| Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses | Q36591648 | ||
| Immunological basis of systemic sclerosis | Q36599181 | ||
| Differential release of mast cell mediators and the pathogenesis of inflammation | Q36819882 | ||
| 'All things considered': transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation | Q38106128 | ||
| STAT6 and lung inflammation | Q38177817 | ||
| Force generation among cells in the relaxing heart | Q39606513 | ||
| Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice | Q40344427 | ||
| Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1. | Q40664842 | ||
| Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo | Q40883930 | ||
| Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells | Q41860961 | ||
| Interleukin 4 is localized to and released by human mast cells | Q41931345 | ||
| Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy | Q42062005 | ||
| Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy | Q42097897 | ||
| Evidence for a role of mast cells in the evolution to congestive heart failure | Q42944600 | ||
| Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis | Q43997200 | ||
| Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells | Q44185531 | ||
| IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells | Q44341556 | ||
| Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. | Q44400944 | ||
| Nutrient intake and serum cytokine pattern in elderly people with heart failure | Q44644383 | ||
| Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. | Q46034399 | ||
| Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway | Q46484361 | ||
| Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin‐4: Analysis of the functional collagen promoter sequences | Q54744477 | ||
| Diastolic Heart Failure — No Time to Relax | Q57073290 | ||
| Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores | Q59052484 | ||
| The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly | Q68428980 | ||
| The IL-4 production capability of different strains of naive CD4(+) T cells controls the direction of the T(h) cell response | Q77373441 | ||
| Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells | Q77862157 | ||
| Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair | Q79074374 | ||
| Cardiac mast cells: implications for heart failure | Q79915077 | ||
| Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts | Q79920047 | ||
| [Interleukin-4 and cardiac fibrosis in patients with heart failure] | Q80702966 | ||
| A pro-fibrotic role for interleukin-4 in cardiac pressure overload | Q83857166 | ||
| Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling | Q83877575 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 582-589 | |
| P577 | publication date | 2015-07-20 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction | |
| P478 | volume | 66 |
| Q37036130 | Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity. |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q48113765 | Anti-inflammatory therapies in myocardial infarction: failures, hopes, and challenges |
| Q41056432 | Circulating Th1, Th2, and Th17 Levels in Hypertensive Patients. |
| Q89658423 | Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring |
| Q37734346 | Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats |
| Q61449101 | Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis |
| Q38615196 | Host regulation of liver fibroproliferative pathology during experimental schistosomiasis via interleukin-4 receptor alpha |
| Q47193481 | Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure. |
| Q48641988 | Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II-Treated Mice |
| Q92549590 | Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases |
| Q99609304 | Mitochondrial dysfunction in fibrotic diseases |
| Q42336183 | Myocardial Metabolism Under Control of a Cytokine Receptor. |
| Q41104298 | New Role for Interleukin-13 Receptor α1 in Myocardial Homeostasis and Heart Failure. |
| Q50662045 | Quantification of Inflammatory Markers in Laryngotracheal Stenosis. |
| Q38601581 | Quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ |
| Q61807003 | Regulation of Type 2 Immunity in Myocardial Infarction |
| Q39255848 | Role of Inflammation in Heart Failure |
| Q88968512 | Role of cytokines and inflammation in heart function during health and disease |
| Q47152878 | Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy |
| Q90233203 | The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis |
Search more.